BC106175 Inhibitors
BC106175, a pivotal cellular regulator, orchestrates various cellular processes, including the modulation of signaling pathways and gene expression. It plays a crucial role in maintaining cellular equilibrium and coordinating essential cellular responses. The general mechanisms of inhibition for BC106175 inhibitors involve targeted disruptions of specific molecular interactions or signaling pathways. BAY 11-7082 disrupts NF-κB signaling, indirectly impacting BC106175 functions. SB-216763 interferes with BC106175-associated processes by disrupting the GSK-3 signaling pathway. SP600125 indirectly influences BC106175 by disrupting JNK signaling, and Rapamycin impacts BC106175 through mTOR signaling. C646 directly influences BC106175 by modulating histone acetylation patterns, and LY294002 indirectly affects BC106175 through the PI3K/AKT pathway.
SB-431542 modulates BC106175-associated signaling cascades by targeting the TGF-β/Smad pathway, while JQ1 directly influences BC106175 through bromodomain activity modulation. PD0325901 indirectly impacts BC106175 functions by disrupting the MAPK/ERK pathway. Niclosamide interferes with BC106175 through STAT3 signaling disruption, and Trichostatin A modulates BC106175 through indirect influence on histone acetylation patterns. These diverse mechanisms collectively illustrate the intricate involvement of BC106175 in cellular processes and offer specific insights into potential targeted interventions in various pathways.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
IKK inhibitor disrupting NF-κB signaling, indirectly impacting BC106175 functions and downstream events. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor interfering with BC106175-associated processes by disrupting GSK-3 signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor disrupting JNK signaling pathway, indirectly influencing BC106175 functions and downstream events. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor disrupting mTOR signaling pathway, indirectly impacting BC106175 functions and downstream events. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
Histone acetyltransferase inhibitor modulating BC106175 through direct influence on histone acetylation patterns. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor interfering with PI3K/AKT pathway, indirectly affecting BC106175 functions and downstream events. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Indirect inhibitor targeting TGF-β/Smad pathway, modulating BC106175-associated signaling cascades. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET bromodomain inhibitor modulating BC106175 through direct influence on bromodomain activity. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
STAT3 inhibitor interfering with STAT3 signaling, indirectly influencing BC106175 functions and downstream events. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor modulating BC106175 through indirect influence on histone acetylation patterns. | ||||||